Orange Book product · Generic (ANDA)
ETOMIDATE
ETOMIDATE
At a glance
Aug 13, 2014
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 13, 2014
12 yr ago
Today
Pharmaceutical detail
Active ingredient
ETOMIDATE
Strength
2MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 204618
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ETOMIDATE
- 1982AMIDATEBrand (NDA)
NDA 018227 · HOSPIRA
- 2020ETOMIDATEGeneric (ANDA)
ANDA 215028 · CAPLIN
- 2017ETOMIDATEGeneric (ANDA)
ANDA 209058 · GLAND
- 2017ETOMIDATEGeneric (ANDA)
ANDA 206126 · EUGIA PHARMA
- 2017ETOMIDATEGeneric (ANDA)
ANDA 201044 · MYLAN LABS LTD
- 2016ETOMIDATEGeneric (ANDA)
ANDA 202354 · HIKMA
- 2014ETOMIDATEGeneric (ANDA)
ANDA 202360 · ZYDUS PHARMS
- 2012ETOMIDATEGeneric (ANDA)
ANDA 091297 · PH HEALTH
- 2009ETOMIDATEGeneric (ANDA)
ANDA 078867 · LUITPOLD
- 2009ETOMIDATEGeneric (ANDA)
ANDA 078289 · RISING
- 1996ETOMIDATEGeneric (ANDA)
ANDA 074593 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
